Dr. Susan B. Legrand, MD

Dr. Legrand practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Legrand's NPI, 1174587794, was assigned on April 12, 2006. Dr. Legrand graduated from School of Medicine Columbia in 1983. Dr. Legrand's Ohio license number on file is 35075194L.

Dr. Legrand's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Legrand's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. The medical group on file is Atrium Health Levine Cancer Institute.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Legrand practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Legrand's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Legrand is board certified in hospice and palliative medicine by the American Board of Anesthesiology. Dmand AI has Dr. Legrand's licenses on file in 5 states: Ohio, South Carolina, North Carolina, Arizona and Texas.

Dmand AI lists breast cancer, colorectal cancer and lung cancer among the conditions Dr. Legrand treats.

CMS data shows 148 Medicare services from Dr. Legrand across 4 procedure codes in 2024, for 58 Medicare patients. Medicare paid $12,681 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 58 Medicare patients who saw Dr. Legrand in 2024. The largest group is 65 to 74, with 28 patients. 72% of them have high blood pressure, and 64% have high cholesterol. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Legrand's median patient age at 65, with 66% women.

In 2024, Dr. Legrand wrote 1,253 Medicare Part D claims for 144 patients. 87% of them were for generic drugs. CMS names the drug for 998 of them, across 28 drugs with 11 or more claims each, at $80,823 in total drug cost. In 2023, CMS named 745 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Legrand for performance year 2024, reported as part of a group. Dr. Legrand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Legrand as offering telehealth.

Dmand AI links 63 papers to Dr. Legrand, published from 2001 to 2021. 2009 was the busiest year, with 4. The most frequent topics are Palliative Care, Analgesics, Opioid and Ohio. Dr. Legrand has published most often in Am J Hosp Palliat Care. Dr. Legrand's most frequent co-authors are Jade Homsi, MD, Mellar P. Davis, MD and Ruth L. Lagman, MD.

CMS Open Payments shows 4 general payments to Dr. Legrand from 2 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 62% of the total. INSYS Therapeutics Inc paid the most, $6,457.

Dmand AI lists 2 awards for Dr. Legrand, most recently CMS Stage 1 EHR in 2013.

Dr. Legrand graduated from School of Medicine Columbia in 1983. Dr. Legrand is a member of AAHPM, ACP and ASCO.

Dr. Legrand is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross and Blue Shield of North Carolina. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.